mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.004 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.007 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.009 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |